Mind Medicine Inc (NASDAQ:MNMD) price on current trading day, rose 16.16% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.68.
A look at the stock’s price movement, the close in the last trading session was $4.89, moving within a range at $4.71 and $5.79. The beta value (5-Year monthly) was 2.393. Turning to its 52-week performance, $11.00 and $4.77 were the 52-week high and 52-week low respectively. Overall, MNMD moved -10.34% over the past month.
Mind Medicine Inc’s market cap currently stands at around $428.09 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-05.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MNMD is a 100% Sell. On the other hand, the stock is on average a 25% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend MNMD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MNMD’s current price about -7.56% and -18.32% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.04, while 7-day volatility ratio is 15.38% and 8.27% in the 30-day chart. Further, Mind Medicine Inc (MNMD) has a beta value of 2.72, and an average true range (ATR) of 0.59. Analysts have given the company’s stock an average 52-week price target of $16, forecast between a low of $16 and high of $16. Looking at the price targets, the low is -181.69% off current price level while to achieve the yearly target high, price needs to move -181.69%. Nonetheless, investors will most likely welcome a -181.69% jump to $16 which is the analysts’ median price.
If we refocus on Mind Medicine Inc (NASDAQ:MNMD), historical trading data shows that trading volumes averaged 1.68 over the past 10 days and 2.01 million over the past 3 months. The company’s latest data on shares outstanding shows there are 75.37 million shares.
The 1.20% of Mind Medicine Inc’s shares are in the hands of company insiders while institutional holders own 49.60% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.37 million on 2025-03-14, giving us a short ratio of 4.92. The data shows that as of 2025-03-14 short interest in Mind Medicine Inc (MNMD) stood at 1510.0001 of shares outstanding, with shares short rising to 10.89 million registered in 2025-02-14. Current price change has pushed the stock -18.39% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MNMD stock continues to rise going into the next quarter.
